Please login to the form below

Not currently logged in
Email:
Password:

New EMG leadership announced

The European Medicines Group has elected Matthew Speers as chair and Steve Turley as vice chair

Matthew Speers has been elected chair of the European Medicines Group (EMG), which represents the UK voice of research-driven pharmaceutical companies headquartered in continental Europe.

Speers is managing director of UCB UK and Ireland, a position he has held since March 2008. In his new capacity as chair, Speers will be supported by Steve Turley, managing director, Lundbeck, who was elected vice chair.

Commenting on his appointment, Speers said: "Despite the tremendous advances in research and development we continue to face considerable market access challenges in the UK with uptake of innovative medicines still lagging significantly behind Europe.

"I am delighted to have been elected to lead the EMG and to continue the work we have undertaken to ensure that all UK citizens have timely access to appropriate, innovative medicines taking other countries in Europe as our benchmark."

Speers succeeds Nigel Brooksby (sanofi-aventis) who led the group for two years.

25th August 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics